These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15773308)

  • 1. [Mechanism of immortalization and tumorigenesis by EBV: overturn of the established theory].
    Sugimoto M; Ide T; Furuichi Y
    Tanpakushitsu Kakusan Koso; 2005 Mar; 50(3):283-8. PubMed ID: 15773308
    [No Abstract]   [Full Text] [Related]  

  • 2. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
    Yamashita Y; Tsurumi T; Mori N; Kiyono T
    Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of innate immunity by the leukotriene B 4 inhibits EBV induced B-cell transformation in cord-blood derived mononuclear cultures.
    Klein E; Liu A; Claesson HE
    Immunol Lett; 2008 Mar; 116(2):174-7. PubMed ID: 18241933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
    Wu Y; Maruo S; Yajima M; Kanda T; Takada K
    J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peptide-based inhibitor for prevention of B cell hyperproliferation induced by Epstein-Barr virus.
    Knight JS; Lan K; Bajaj B; Sharma N; Tsai DE; Robertson ES
    Virology; 2006 Oct; 354(1):207-14. PubMed ID: 16876848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.
    Lan K; Verma SC; Murakami M; Bajaj B; Robertson ES
    Curr Protoc Microbiol; 2007 Aug; Chapter 14():Unit 14E.2. PubMed ID: 18770612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A B-lymphocyte binding peptide from BNRF1 induced antibodies inhibiting EBV-invasion of B-lymphocytes.
    López R; Urquiza M; Patino H; Suárez J; Reyes C; Patarroyo MA; Patarroyo ME
    Biochimie; 2005 Nov; 87(11):985-92. PubMed ID: 15927339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
    Johnson LR; Nalesnik MA; Swerdlow SH
    Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
    Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
    Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin induces lytic cytotoxicity in Epstein-Barr virus-positive cells.
    Liu SF; Wang H; Li ZJ; Deng XY; Xiang H; Tao YG; Li W; Tang M; Cao Y
    Eur J Pharmacol; 2008 Jul; 589(1-3):8-13. PubMed ID: 18571159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine promotes epstein-barr virus-infected human B-cell transformation assayed by three correlated assay methods.
    Chen C; Johnston TD; Jeon H; Gedaly R; McHugh P; Ranjan D
    Transplant Proc; 2009; 41(1):366-70. PubMed ID: 19249558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBV transformation overrides gene expression patterns of B cell differentiation stages.
    Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
    Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of human B lymphocyte activation. II. Determination of EBV-stimulated B cell function].
    Oshikawa T; Funato T; Koide A; Ohtani H; Saito M
    Rinsho Byori; 1983 May; 31(5):534-8. PubMed ID: 6313993
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
    Liu JP; Cassar L; Pinto A; Li H
    Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for a gene involved in the determination of limited duplicative capacity in human cells.
    Calef E; Scotto d'Abusco A; Bianchi E; Gargano S; Fruscalzo A
    Genetica; 1994; 94(2-3):249-53. PubMed ID: 7896143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis.
    Widmann TA; Herrmann M; Taha N; König J; Pfreundschuh M
    Exp Hematol; 2007 Jun; 35(6):939-46. PubMed ID: 17533048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere uncapping, chromosomes, and carcinomas.
    Batista LF; Artandi SE
    Cancer Cell; 2009 Jun; 15(6):455-7. PubMed ID: 19477422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.